Inferior Vena Cava Filters Lawsuits IncreaseJun 28, 2016
The inferior vena cava (IVC) is a large vein that carries de-oxygenated blood from the lower body to the heart. The blood comes from the legs and the lower torso of the body. The inferior vena cava empties into the right atrium of the heart. The vein runs alongside the right vertebral column of the spine.
For those patients who are unable to take anticoagulants, an alternative recommended by a doctor may be the use of an IVC filter, according to Digital Journal.
However, complications have been associated with the IVC filter, as reported by the U.S. Food and Drug Administration in May 2014. Serious side effects that have been reported including device migration, perforation of the IVC, embolization (movement of the filter or fractured fragments to the heart or lungs), and difficulty removing the device, reports Digital Journal.
The average implantation period for the IVC filter involved in a study was 63 days, ranging from 20 to 270 days. The longer the filter is implanted, the greater the increase in tissue formation around the filter hook within the wall of the IVC.
As a result of these claims, many patients have filed lawsuits against the manufacturer for poor design, and warning to fail of risks. In 2012, lawsuits were filed against Bard in California and Pennsylvania state courts and were combined with a Multidistrict Litigation (MDL) Panel in the U.S. District of Arizona in 2015.